Neocate In Infants and Children With Complex Conditions

Exclusion Criteria

• •Infants born with a gestational age \<37 weeks that are \<40 weeks corrected age at the time of study entry (V1).
• •Infants or children with endoscopically confirmed eosinophilic oesophagitis and prescribed an amino acid-based formula only for the management of the eosinophilic oesophagitis.
• •Infants or children with a medical diagnosis that includes only (suspected) cow's milk allergy and/or multiple food allergy.
• •Infants or children with renal dysfunction, e.g. acute or chronic kidney failure or kidney cancer.
• •Infants or children with thyroid disorder or parathyroid disorder.
• •Expected to receive parenteral nutrition during intervention from study entry (V1).
• •Participation in any other studies involving investigational or marketed products concomitantly or within 1 month prior to study entry (V1).
• •Investigator's uncertainty about the willingness or ability of the parents/guardians to comply with the protocol requirements.